Bone Cancer News

Denosumab Active Against Giant Cell Tumor of Bone (February 11, 2010)

In a Phase II clinical trial, denosumab produced high rates of tumor response among patients with recurrent or unresectable giant cell tumors of bone. These results were published in Lancet Oncology. Denosumab is an investigational drug that targets... Continue Reading

Latest Bone Cancer News By Stage


General Bone Cancer

Denosumab Active Against Giant Cell Tumor of Bone (February 11, 2010)

In a Phase II clinical trial, denosumab produced high rates of tumor response among patients with recurrent or unresectable giant cell tumors of bone. These results were published in Lancet Oncology. Denosumab is an investigational drug that targets... Continue Reading

More General Bone Cancer